At the upcoming ESTIV2024 meeting, Dr. Vijay Gombar will showcase groundbreaking advancements made by Sciome in the development of OrbiTox—an innovative interactive 3D visualization and data analysis platform designed specifically for predictive toxicology and translational discovery. As the scientific community increasingly moves away from traditional animal testing methods, the resulting shift toward New Approach Methodologies (NAMs) generates vast amounts of complex, detailed data that are often challenging to analyze and utilize effectively.
Sciome’s pioneering approach integrates advanced data clustering, machine learning, and visualization techniques into a revolutionary 3D environment. OrbiTox hosts millions of interconnected scientific data points, both experimentally derived and computationally predicted, providing researchers with seamless and intuitive access to toxicologically relevant information. The platform curates extensive datasets comprising 900,000 substances, 22,000 human targets, 2,000 biological pathways, over 200 test organisms, and robust QSAR models for more than 40 Tox21 assays and bacterial mutagenicity tests. Users can effortlessly query across multiple domains, significantly enhancing data-driven discovery.
OrbiTox’s cutting-edge technology allows real-time data interaction and is scalable to handle several million data points efficiently, setting it apart from existing data visualization frameworks. To date, no other platform offers a comparable combination of advanced functionality, intuitive interactivity, and extensive toxicological insights.
The 22nd International Congress of the European Society of Toxicology In Vitro (ESTIV2024), scheduled for June 3-6, 2024, in Prague, Czech Republic, is a premier international event that brings together global researchers, toxicologists, and students dedicated to advancing in vitro and in silico toxicological methodologies.
